EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Aβ-oligomers: A potential therapeutic target for Alzheimer's disease

Sudeshna Ghosh, Rafat Ali, Sandeep Verma

International Journal of Biological Macromolecules · 2023-06 · 239 · 124231

DOI: 10.1016/j.ijbiomac.2023.124231 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Biological Macromolecules, 2023-06. Verfasst von Sudeshna Ghosh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur, UP 208016, India. Electronic address: sudeshnag85@gmail.com. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 189 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cascade of amyloid formation relates to multiple complex events at the molecular level. Previous research has established amyloid plaque deposition as the leading cause of Alzheimer's disease (AD) pathogenesis, detected mainly in aged population. The primary components of the plaques are two alloforms of amyloid-beta (Aβ), Aβ1-42 and Aβ1-40 peptides. Recent studies have provided considerable evidence contrary to the previous claim indicating that amyloid-beta oligomers (AβOs) as the main culprit responsible for AD-associated neurotoxicity and pathogenesis. In this review, we have discussed the primary features of AβOs, such as assembly formation, the kinetics of oligomer formation, interactions with various membranes/membrane receptors, the origin of toxicity, and oligomer-specific detection methods. Recently, the discovery of rationally designed antibodies has opened a gateway for using synthesized peptides as a grafting component in the complementarity determining region (CDR) of antibodies. Thus, the Aβ sequence motif or the complementary peptide sequence in the opposite strand of the β-sheet (extracted from the Protein Data Bank: PDB) helps design oligomer-specific inhibitors. The microscopic event responsible for oligomer formation can be targeted, and thus prevention of the overall macroscopic behaviour of the aggregation or the associated toxicity can be achieved. We have carefully reviewed the oligomer formation kinetics and associated parameters. Besides, we have depicted a thorough understanding of how the synthesized peptide inhibitors can impede the early aggregates (oligomers), mature fibrils, monomers, or a mixture of the species. The oligomer-specific inhibitors (peptides or peptide fragments) lack in-depth chemical kinetics and optimization control-based screening. In the present review, we have proposed a hypothesis for effectively screening oligomer-specific inhibitors using the chemical kinetics (determining the kinetic parameters) and optimization control strategy (cost-dependent analysis). Further, it may be possible to implement the structure-kinetic-activity-relationship (SKAR) strategy instead of structure-activity-relationship (SAR) to improve the inhibitor's activity. The controlled optimization of the kinetic parameters and dose usage will be beneficial for narrowing the search window for the inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansAgedAmyloid beta-PeptidesPeptide FragmentsAmino Acid SequenceAmyloidPlaque, Amyloid

Stichwörter der Autor:innen

AβOsChemical kineticsDesigned antibodyOptimal control strategyPeptide-based inhibitors

Substanzen

Amyloid beta-PeptidesPeptide FragmentsAmyloid

Autor:innen und Institutionen

  • Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur, UP 208016, India. Electronic address: sudeshnag85@gmail.com.
  • Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur, UP 208016, India.
  • Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur, UP 208016, India. Electronic address: sverma@iitk.ac.in.

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Ghosh, S., Ali, R., & Verma, S. (2023). Aβ-oligomers: A potential therapeutic target for Alzheimer's disease. International Journal of Biological Macromolecules, 239, 124231. https://doi.org/10.1016/j.ijbiomac.2023.124231

Vancouver

Ghosh S, Ali R, Verma S. Aβ-oligomers: A potential therapeutic target for Alzheimer's disease. International Journal of Biological Macromolecules. 2023;239:124231. doi:10.1016/j.ijbiomac.2023.124231

BibTeX
@article{Ghosh2023,
  author = {Ghosh, Sudeshna and Ali, Rafat and Verma, Sandeep},
  title = {Aβ-oligomers: A potential therapeutic target for Alzheimer's disease},
  journal = {International Journal of Biological Macromolecules},
  year = {2023},
  volume = {239},
  pages = {124231},
  doi = {10.1016/j.ijbiomac.2023.124231}
}
Kostenlos starten →